Most sold healthcare stocks in Q4 2014
See which Healthcare stocks institutional investors trimmed or exited the most in Q4 2014, measured as net reductions in reported share positions from Q3 2014 into Q4 2014. Notable reductions at the top of this list include BOSTON SCIENTIFIC CORP (BSX), STRYKER CORP (SYK), ABBVIE INC (ABBV), JOHNSON & JOHNSON (JNJ). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BSX | BOSTON SCIENTIFIC CORP | -40,164,976 | -$464.81M | 0 | 1 | 2 | 0 | 3 |
| SYK | STRYKER CORP | -11,964,919 | -$829.05M | 0 | 1 | 4 | 1 | 5 |
| ABBV | ABBVIE INC | -11,341,410 | -$606.13M | 3 | 2 | 4 | 2 | 9 |
| JNJ | JOHNSON & JOHNSON | -8,717,263 | -$976.30M | 0 | 7 | 11 | 0 | 20 |
| PDCO | PATTERSON COS INC | -6,346,959 | -$199.43M | 0 | 1 | 4 | 1 | 5 |
| BDX | BECTON DICKINSON AND CO | -4,529,712 | -$297.01M | 0 | 4 | 6 | 1 | 11 |
| ABT | ABBOTT LABORATORIES | -3,628,370 | -$60.19M | 0 | 1 | 10 | 0 | 12 |
| MRK | MERCK & CO. INC. | -2,922,234 | -$263.36M | 0 | 3 | 7 | 2 | 13 |
| TMO | THERMO FISHER SCIENTIFIC INC | -2,202,809 | -$219.72M | 0 | 4 | 5 | 0 | 10 |
| GILD | GILEAD SCIENCES INC | -1,663,452 | -$294.85M | 2 | 9 | 3 | 1 | 14 |
| PHG | KONINKLIJKE PHILIPS NVR- NY | -1,544,308 | -$134.86M | 0 | 0 | 3 | 0 | 3 |
| ACAD | ACADIA PHARMACEUTICALS INC | -1,368,624 | -$13.22M | 0 | 0 | 1 | 0 | 1 |
| MOH | MOLINA HEALTHCARE INC | -1,124,232 | -$45.50M | 0 | 1 | 0 | 1 | 1 |
| REGN | REGENERON PHARMACEUTICALS | -1,116,853 | -$375.68M | 0 | 0 | 1 | 2 | 1 |
| LLY | ELI LILLY & CO | -1,062,219 | -$50.70M | 0 | 1 | 4 | 1 | 5 |
| TFX | TELEFLEX INC | -792,164 | -$68.35M | 0 | 1 | 3 | 0 | 4 |
| GERN | GERON CORP | -639,378 | $670.00K | 1 | 0 | 1 | 0 | 2 |
| SRDX | SURMODICS INC | -615,550 | -$8.02M | 0 | 1 | 2 | 0 | 3 |
| GMED | GLOBUS MEDICAL INC - A | -602,400 | -$10.82M | 0 | 0 | 1 | 0 | 1 |
| RMD | RESMED INC | -547,100 | -$23.88M | 1 | 0 | 0 | 1 | 1 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | -527,964 | -$17.09M | 0 | 0 | 0 | 1 | 0 |
| CYTK | CYTOKINETICS INC | -498,161 | -$1.75M | 0 | 0 | 0 | 1 | 0 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -490,608 | -$106.15M | 0 | 1 | 1 | 0 | 2 |
| CPIX | CUMBERLAND PHARMACEUTICALS | -485,025 | -$101.00K | 0 | 1 | 1 | 0 | 2 |
| SEM | SELECT MEDICAL HOLDINGS CORP | -390,300 | -$4.70M | 0 | 0 | 0 | 1 | 0 |
| CVS | CVS HEALTH CORP | -377,020 | $81.78M | 0 | 1 | 8 | 0 | 9 |
| MCK | MCKESSON CORP | -338,784 | -$57.75M | 0 | 0 | 1 | 1 | 1 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | -321,440 | -$5.17M | 0 | 0 | 6 | 0 | 8 |
| ARAY | ACCURAY INC | -319,040 | -$2.03M | 0 | 0 | 1 | 0 | 1 |
| WST | WEST PHARMACEUTICAL SERVICES | -312,200 | -$6.00M | 0 | 0 | 1 | 0 | 1 |
| GRFS | GRIFOLS SA-ADR | -271,900 | -$9.66M | 0 | 0 | 1 | 0 | 1 |
| BRKR | BRUKER CORP | -255,960 | -$4.74M | 0 | 0 | 0 | 1 | 0 |
| MASI | MASIMO CORP | -236,100 | -$4.52M | 0 | 0 | 1 | 0 | 1 |
| CPRX | CATALYST PHARMACEUTICALS INC | -196,500 | -$652.00K | 0 | 0 | 0 | 1 | 0 |
| RDNT | RADNET INC | -195,600 | -$647.00K | 0 | 0 | 1 | 0 | 1 |
| CNMD | CONMED CORP | -180,481 | -$6.65M | 0 | 0 | 0 | 1 | 0 |
| RGEN | REPLIGEN CORP | -161,200 | -$3.29M | 0 | 0 | 1 | 0 | 1 |
| A | AGILENT TECHNOLOGIES INC | -159,478 | -$81.21M | 0 | 2 | 1 | 2 | 3 |
| ILMN | ILLUMINA INC | -114,265 | $170.78M | 0 | 1 | 1 | 0 | 4 |
| ALKS | ALKERMES PLC | -91,800 | -$2.93M | 0 | 0 | 1 | 0 | 1 |
| CCRN | CROSS COUNTRY HEALTHCARE INC | -89,100 | -$628.00K | 0 | 0 | 1 | 0 | 1 |
| ENTA | ENANTA PHARMACEUTICALS INC | -83,277 | -$3.29M | 0 | 0 | 0 | 1 | 0 |
| NEOG | NEOGEN CORP | -81,013 | -$3.20M | 0 | 0 | 0 | 1 | 0 |
| AMN | AMN HEALTHCARE SERVICES INC | -75,200 | -$943.00K | 0 | 0 | 1 | 0 | 1 |
| ATR | APTARGROUP INC | -75,100 | -$4.30M | 0 | 0 | 1 | 0 | 2 |
| NEO | NEOGENOMICS INC | -65,800 | -$485.00K | 0 | 0 | 1 | 0 | 1 |
| FMS | FRESENIUS MEDICAL CARE-ADR | -61,800 | -$2.09M | 0 | 0 | 1 | 0 | 1 |
| AORT | ARTIVION INC | -61,700 | -$145.00K | 0 | 0 | 1 | 0 | 1 |
| PFMT | PERFORMANT FINANCIAL CORP | -60,700 | -$776.00K | 0 | 0 | 1 | 0 | 1 |
| OSUR | ORASURE TECHNOLOGIES INC | -59,700 | $961.00K | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q4 2014
What are the most sold Healthcare stocks in Q4 2014?
The most sold healthcare stocks in Q4 2014 are those with the largest decrease in reported share counts across institutional investors compared to Q3 2014, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q4 2014?
Among filers in this sector, net reductions were largest in companies such as BOSTON SCIENTIFIC CORP (BSX), STRYKER CORP (SYK), ABBVIE INC (ABBV), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2014).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.